ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer

SOUTH SAN FRANCISCO, Calif., and VANCOUVER, Canada, April 12, 2023. ESSA Pharma Inc. ( " ESSA " , or the " Company " ), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials